Invitae to acquire Genosity for $200m, lands $1.15bn investment

Genetic testing company Invitae has entered into an agreement to acquire genomics firm Genosity for $200m, alongside landing a $1.15bn investment …

  • You already voted!
  • Read More

Get Unlimited Free Access

Join 6,000 other readers who get their news from us